I’ve been away from my desk for most of the day, but I wanted to recommend (very highly) the following Scientific American piece by Helen Branswell on the fallout from the recent laboratory incidents involving select agents at the CDC and FDA.
So-called gain-of-function pathogen research will likely receive closer scrutiny after three U.S. biolab incidents
Jul 14, 2014 |By Helen Branswell
A CDC scientist inoculates a chicken egg with H5N1 in a biosafety level 3 lab.
Credit: CDC/Greg Knobloch
There had to be a sinking feeling in the chest of every researcher who works in a high-containment research laboratory last Friday when the U.S. Centers for Disease Control and Prevention (CDC) released its report on three worrisome incidents that raised safety questions at two well-respected government facilities. But it is likely the sensation was most acute for the influenza scientists who work in a controversial field known as gain-of-function research.